...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

Does it make sense for Zenith Capital Corp., to go totally private? This way it will lose its ZHCLF OTC $0.25-$0.30 US sting.

Don should have gone with an IPO years ago.

 

Koo

Share
New Message
Please login to post a reply